东华能源公告，控股股东一致行动人马森能源（张家港）有限公司于2025年9月22日至9月30日通过集中 竞价增持公司股份3152万股，占总股本2.00%，累计增持金额2.77亿元；本次增持计划实施完成后，东 华石油及其一致行动人合计持有公司股份6.72亿股，占总股本42.67%。 ...

中国海洋石油(00883)发布公告，于2025年4月9日至2025年10月8日期间，公司实际控制人中国海油 （600938）集团通过港股通交易系统累计增持公司港股股份2209.8万股，约占公司已发行股份总数的 0.05%，增持金额累计人民币3.32亿元( 含税费)。上述增持实施后，中国海油集团及其一致行动人直接 或间接持有公司合计395.3亿股股份，约占公司已发行股份总数的62.13%。 ...

中国海洋石油有限公司公告实控人增持股份进展。2025 年 4 月 9 日披露增持计划，中国海油集团拟 12 个月内增持 A 股及港股，金额 20 - 40 亿元。截至 10 月 8 日，累计增持港股 22,098,000 股，占总股本 0.05%，金额 3.32 亿元（不含税费）。增持主体为控股股东、实控人，增持前持股 735,626,000 股港 股，占比 1.55%。本次增持计划可能因市场变化等无法达预期，原定增持计划已过半，但实际增持金额 未到下限 50%，后续将继续择机增持。 ...

【环球网财经综合报道】2025年以来，A股市场上市公司大股东及高管增持力度保持强劲态势。Wind最新数据显示，截至10月4日，已有超500家 上市公司股东实施增持计划，累计增持金额近750亿元。 南京银行作为总市值超1350亿元的商业银行，其股东增持动作受市场关注。9月28日公告显示，公司大股东法国巴黎银行（QFII）于2025年9月22 日至26日期间，通过上海证券交易所交易系统以集中竞价方式增持公司股份1.08亿股，占总股本的0.87%，使得法国巴黎银行及法国巴黎银行 （QFII）合计持股比例由16.14%提升至17.02%。值得注意的是，这已是南京银行近两个月内再度获得重要股东增持，自年初以来已连续获得多位 股东频繁增持。9月22日，南京银行与法国巴黎银行签署了战略合作备忘录，法国巴黎银行首席执行官柏诺飞在签约时表示，希望深化双方战略合 作关系。 总市值超1100亿元的盐湖股份主要产品为碳酸锂等。8月6日公告披露，公司实控人中国五矿通过集中竞价和大宗交易方式，于2025年5月20日至8 月6日累计增持公司股份2.48亿股，占总股本的4.69%，已完成增持计划下限。9月28日，盐湖股份宣布其4万吨/年基础 ...

| 证券简称 | 涉及股东人数 | 净买入股份数合计 | 增仓参考市值 | 所属Wind行业 | | --- | --- | --- | --- | --- | | | | (万股) | (亿元) | | | 南京银行 | র্ব | 54545. 30 | 59. 17 | 银行 | | 盐湖股份 | 1 | 24809. 33 | 45. 49 | 化工 | | 比亚迪 | 7 | 1120. 32 | 29. 87 | 汽车与零配件 | | 华菱钢铁 | 1 | 48088. 75 | 25. 15 | 钢铁 II | | 格力电器 | 1 | 4638. 27 | 21. 18 | 家电 II | | 东方盛虹 | 3 | 23297.21 | 20. 71 | 化工 | | 中国巨石 | 2 | 14151.41 | 16. 09 | 建材 II | | 上海菜士 | 5 | 21928. 86 | 15. 13 | 医药生物 | | 苏州银行 | 15 | 18201.99 | 14. 33 | 银行 | | 赛轮轮胎 | 1 | 9596. 67 | 12. 94 | 汽车与零配件 | | 光大 ...

此前，沧港铁路发布2025年中期业绩，收益1.32亿元(人民币，下同)，同比下降0.3%;公司权益股东应占 溢利3087.8万元，同比增长17.2%；每股基本盈利0.80分。公告称，期内溢利同比增加，主要由于透过 损益按公平值计量的上市股份的公平值收益所产生的其他收入，以及公司的财务成本及经营开支下降， 反映公司战略措施的成功执行。 智通财经APP获悉，沧港铁路(02169)高开逾5%，截至发稿，涨5.68%，报0.93港元，成交额357.68万港 元。 消息面上，根据香港联交所9月29日披露的文件，河北沧州交控集团有限责任公司于9月24日以每股均价 0.8197港元增持沧港铁路3.02亿股普通股股份，价值约2.47亿港元。增持后，河北沧州交控集团有限责 任公司最新持股数目为3.02亿股股份，好仓比例由0.00%升至7.55%。 ...

Group 1: Institutional Research on Popular Companies - The top twenty companies with the highest number of institutional research visits in the past 30 days include Mindray Medical, Huichuan Technology, United Imaging Healthcare, Shenzhen South Circuit, and Aibo Medical [11][13] - In the last five days, the most popular companies for institutional research include Jepu Tech, Ganli Pharmaceutical, Shiji Information, Guangri Co., and Nenghui Technology [11][12] - Among the top twenty companies in the past 30 days, 12 companies had 10 or more rating agencies involved, with significant profit growth expected for Lankai Technology, Huichuan Technology, and Sanhua Intelligent Control in their 2025 mid-year reports compared to 2024 [11][12] Group 2: Shareholder Increase and Buyback Strategies - From September 22 to September 26, 2025, four listed companies announced significant shareholder increases [18] - A total of 71 companies announced buyback progress during the same period, with 22 of them having 10 or more rating agencies involved [24] - From January 1 to September 26, 2025, 274 companies announced shareholder increases, with 86 of them having 10 or more rating agencies involved [20] Group 3: Buyback Situation - From January 1 to September 26, 2025, 1,747 companies announced buyback progress, with 414 of them having 10 or more rating agencies involved [26] - Among these, 108 companies had a buyback amount that exceeded 1% of their market value on the announcement date [26][27] - Specific companies in the buyback phase include Chengde Lulu, Liugong, Shantui, Huaming Equipment, Jian Sheng Group, Ruoyu Chen, and China Jushi [27]

登录新浪财经APP 搜索【信披】查看更多考评等级 股东信泰人寿保险股份有限公司保证向本公司提供的信息内容真实、准确、完整，没有虚假记载、误导 性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 重要内容提示： 基于对湖南华菱钢铁股份有限公司（以下简称"公司"或"华菱钢铁"）未来发展前景的坚定信心及中长期 投资价值的认可，信泰人寿保险股份有限公司（以下简称"信泰人寿"）于2025年9月11日披露了增持计 划，自增持计划披露日起6个月内，继续增持公司股份数量不低于总股本的1%（即69,086,400股）且不 超过总股本的2%（即138,172,700股）。 作为公司持股5%以上股东，信泰人寿于2025年9月12日至2025年9月26日期间以集中竞价交易方式累计 增持公司股份69,086,346股。截至本公告披露日，信泰人寿持有公司股份 483,604,221股，占公司总股本 的7%，持股变动触及1%的整数倍。本次增持计划数量已经过半，增持计划尚未实施完毕，信泰人寿将 继续实施增持计划。 2025年9月26日，公司收到大股东信泰人寿出具的《关于增持华菱钢铁股份触及1%整数倍暨增持 ...

Core Viewpoint - The company, 帝欧水华集团股份有限公司, has received a commitment letter from 中信银行成都分行 for a special loan to support stock purchases by its major shareholder, 四川发展证券投资基金管理有限公司, which aims to enhance its stake in the company [3][6]. Group 1: Loan Commitment and Purpose - The special loan commitment from 中信银行成都分行 amounts to a maximum of RMB 54 million, with a borrowing period not exceeding 36 months [3][6]. - The funds from this loan will be exclusively used for the purpose of increasing the shareholding in 帝欧水华 through centralized bidding transactions [7]. Group 2: Shareholding and Purchase Plan - As of the announcement date, the major shareholder holds 27,657,037 shares, representing 5.39% of the company's total share capital [5]. - The shareholder plans to increase its holdings by investing between RMB 40 million and RMB 60 million within six months, with a maximum purchase price of RMB 10 per share for stocks, while there is no price limit for convertible bonds [4].

Core Viewpoint - The major shareholder, Xintai Life Insurance Co., Ltd., has initiated a share buyback plan for Hunan Huazhong Steel Co., Ltd., expressing confidence in the company's future development and long-term investment value [3][4]. Group 1: Buyback Plan Details - Xintai Life announced a plan to increase its shareholding by at least 1% (69,086,400 shares) and up to 2% (138,172,700 shares) within six months starting from September 11, 2025 [3][4]. - As of the announcement date, Xintai Life has already acquired 69,086,346 shares, raising its total holdings to 483,604,221 shares, which is 7% of the total share capital [4][6]. Group 2: Implementation Progress - The buyback was executed through centralized bidding on the Shenzhen Stock Exchange from September 12 to September 26, 2025, with the total shares acquired representing 1% of the company's total share capital [4][5]. - The buyback plan is still ongoing, with more than half of the planned shares already purchased [4][6]. Group 3: Compliance and Regulations - The buyback plan complies with relevant laws and regulations, including the Company Law and Securities Law of the People's Republic of China [6]. - Xintai Life has committed to not reducing its shareholdings during the buyback period and will adhere to all applicable trading regulations [5][6].